Molecular insight into the T798M gatekeeper mutation-caused acquired resistance to tyrosine kinase inhibitors in ErbB2-positive breast cancer.

Lu, Ji; Zhou, Kun; Yin, Xiaoxing; Xu, Han; Ma, Baojin.
Comput Biol Chem; 78: 290-296, 2019 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-30605854